At a glance
ClinicalIndex Comparison RecordN/ACompleted· 204 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Pharmacogenetic Factors Contributing to Dose Requirement of Fentanyl for Postoperative Pain Control: Genetic Polymorphisms of OPRM1, ABCB1, CYP3A4 and CYP3A5
In Brief
An observational study for Pain, Postoperative. Completed, enrolled 204 participants across 1 site.
Detailed Summary
Fentanyl is a widely used opioid analgesic. There are big interindividual variabilities in dose requirements of fentanyl for postoperative pain control. This study aims to reveal the genetic factors affecting the variable requirements of fentanyl during postoperative period.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2008
First PostedJan 2009
Primary CompletionDec 2010
Study CompletionDec 2012
TodayJul 2026
First PostedJan 19, 2009
Enrollment StartSep 1, 2008
Primary CompletionDec 1, 2010
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.5 years ago